Spero Therapeutics (SPRO) SEC Filings & 10K Form

$1.63
+0.02 (+1.24%)
(As of 05/3/2024 ET)

Recent Spero Therapeutics SEC Filings

DateFilerForm TypeView
04/16/2024
3:11 PM
Spero Therapeutics (Filer)
Form DEF 14A
04/16/2024
3:15 PM
Spero Therapeutics (Filer)
Form DEFA14A
04/16/2024
3:19 PM
Spero Therapeutics (Filer)
Form ARS
03/29/2024
3:06 PM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2024
11:15 PM
Spero Therapeutics (Filer)
Form EFFECT
03/15/2024
3:34 PM
Spero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/15/2024
3:18 PM
Spero Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2024
3:07 PM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:10 PM
Spero Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
3:25 PM
Anson Funds Management LP (Filed by)
Spero Therapeutics (Subject)
Form SC 13G
02/05/2024
7:48 PM
JOSEPH TAMARA L (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
7:50 PM
Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
7:53 PM
Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
7:40 PM
Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
7:44 PM
Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
7:45 PM
HAMED KAMAL (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:50 PM
Shukla Sath (Reporting)
Spero Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
5:07 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
7:11 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:40 PM
Spero Therapeutics (Issuer)
Tregoning Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:13 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
3:45 PM
Spero Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/01/2023
7:10 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
3:01 PM
Spero Therapeutics (Filer)
Form 8-K/A
10/10/2023
4:34 PM
Deshpande Milind (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:39 PM
Spero Therapeutics (Issuer)
THOMAS FRANK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:40 PM
Smith Cynthia (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:43 PM
Pottage John C Jr (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:18 PM
Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:19 PM
Jackson Scott Thomas (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:28 PM
Spero Therapeutics (Issuer)
VINK PATRICK V.J.J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:29 PM
Spero Therapeutics (Issuer)
Tregoning Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
7:28 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
4:47 PM
HAMED KAMAL (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:20 PM
Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:21 PM
Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:22 PM
JOSEPH TAMARA L (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:23 PM
Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2023
3:16 PM
Shukla Sath (Reporting)
Spero Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2023
4:27 PM
Spero Therapeutics (Filer)
Form PRE 14A
07/31/2023
7:12 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Gold Mania (Ad)

Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).

See his free reveal right here.
07/24/2023
3:46 PM
DiPalma Stephen J. (Reporting)
Spero Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2023
7:30 AM
HAMED KAMAL (Reporting)
Spero Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
7:12 AM
Spero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SPRO) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners